Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Jolly

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Journal of Virology|February 11, 1999
Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectorsM Gasmi, J Glynn, M J Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Gene expression from transcriptionally disabled retroviral vectorsJ K Yee, J C Moores, D J Jolly, et al.
The Journal of Rheumatology|June 19, 1998
Direct synovial gene transfer with retroviral vectors in rat adjuvant arthritisK H Nguyen, D L Boyle, J E McCormack, et al.
Intervirology|January 1, 1997
Retroviral-mediated expression of FIV envelope/Rev induces CD8+ CTL responses in miceU von Schwedler, K Townsend, S Chada, et al.
AIDS Research and Human Retroviruses|August 1, 1991
Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cellsJ F Warner, C G Anderson, L Laube, et al.
Cancer Gene Therapy|October 7, 2000
Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patientsS Fujii, S Huang, T C Fong, et al.
The Journal of Clinical Investigation|December 15, 1996
Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytesA Bosch, P B McCray, S M Chang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serumN J DePolo, J D Reed, P L Sheridan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Antigen presentation in retroviral vector-mediated gene transfer in vivoE S Song, V Lee, C D Surh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2001
Factors affecting long-term expression of a secreted transgene product after intravenous administration of a retroviral vectorJ E McCormack, W Edwards, J Sensintaffer, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Virology|February 11, 1999
Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectorsM Gasmi, J Glynn, M J Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Gene expression from transcriptionally disabled retroviral vectorsJ K Yee, J C Moores, D J Jolly, et al.
The Journal of Rheumatology|June 19, 1998
Direct synovial gene transfer with retroviral vectors in rat adjuvant arthritisK H Nguyen, D L Boyle, J E McCormack, et al.
Intervirology|January 1, 1997
Retroviral-mediated expression of FIV envelope/Rev induces CD8+ CTL responses in miceU von Schwedler, K Townsend, S Chada, et al.
AIDS Research and Human Retroviruses|August 1, 1991
Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cellsJ F Warner, C G Anderson, L Laube, et al.
Cancer Gene Therapy|October 7, 2000
Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patientsS Fujii, S Huang, T C Fong, et al.
The Journal of Clinical Investigation|December 15, 1996
Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytesA Bosch, P B McCray, S M Chang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serumN J DePolo, J D Reed, P L Sheridan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Antigen presentation in retroviral vector-mediated gene transfer in vivoE S Song, V Lee, C D Surh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2001
Factors affecting long-term expression of a secreted transgene product after intravenous administration of a retroviral vectorJ E McCormack, W Edwards, J Sensintaffer, et al.
Pageof 7